US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
US5049578A
(en)
|
1990-03-09 |
1991-09-17 |
E. R. Squibb & Sons, Inc. |
1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
US6403609B1
(en)
|
1997-07-29 |
2002-06-11 |
Alcon Manufacturing, Ltd. |
Ophthalmic compositions containing galactomannan polymers and borate
|
EP1051167A1
(en)
|
1998-01-29 |
2000-11-15 |
Sepracor, Inc. |
Pharmaceutical uses of optically pure (-) -bupropion
|
CA2331735A1
(en)
|
1998-05-08 |
1999-11-18 |
Smithkline Beecham P.L.C. |
Phenylurea and phenylthio urea derivatives
|
DE60015927T2
(de)
|
1999-02-12 |
2005-04-07 |
Smithkline Beecham P.L.C., Brentford |
Phenylharnstoff und phenylthioharnstoffderivate
|
WO2000047577A1
(en)
|
1999-02-12 |
2000-08-17 |
Smithkline Beecham Plc |
Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
|
WO2000047576A1
(en)
|
1999-02-12 |
2000-08-17 |
Smithkline Beecham Plc |
Cinnamide derivatives as orexin-1 receptors antagonists
|
JP2003500386A
(ja)
|
1999-05-24 |
2003-01-07 |
シーオーアール セラピューティクス インコーポレイテッド |
Xa因子阻害剤
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
AU779266B2
(en)
|
2000-05-11 |
2005-01-13 |
Banyu Pharmaceutical Co., Ltd. |
N-acyltetrahydroisoquinoline derivatives
|
PT1289955E
(pt)
|
2000-06-16 |
2005-08-31 |
Smithkline Beecham Plc |
Piperidinas para utilizacao como antagonistas dos receptores da orexina
|
ATE286897T1
(de)
|
2000-11-28 |
2005-01-15 |
Smithkline Beecham Plc |
Morpholinderivate als antagonisten an orexinrezeptoren
|
WO2002051232A2
(en)
|
2000-12-27 |
2002-07-04 |
Actelion Pharmaceuticals Ltd. |
Novel benzazepines and related heterocyclic derivatives
|
JP2004534026A
(ja)
|
2001-05-05 |
2004-11-11 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
オレキシン受容体アンタゴニストとしてのn−アロイルサイクリックアミン誘導体
|
ATE383359T1
(de)
|
2001-05-05 |
2008-01-15 |
Smithkline Beecham Plc |
N-aroyl zyklische amine
|
GB0115862D0
(en)
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
GB0126292D0
(en)
|
2001-11-01 |
2002-01-02 |
Smithkline Beecham Plc |
Compounds
|
GB0127145D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Compounds
|
GB0130393D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
GB0130335D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
GB0130341D0
(en)
|
2001-12-19 |
2002-02-06 |
Smithkline Beecham Plc |
Compounds
|
US7067519B2
(en)
|
2002-07-09 |
2006-06-27 |
Hamed Aissaoui |
7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
|
WO2004026866A1
(en)
|
2002-09-18 |
2004-04-01 |
Glaxo Group Limited |
N-aroyl cyclic amines as orexin receptor antagonists
|
EP1554239B1
(en)
|
2002-10-11 |
2011-01-26 |
Actelion Pharmaceuticals Ltd. |
Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
|
GB0225884D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225944D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
GB0225938D0
(en)
|
2002-11-06 |
2002-12-11 |
Glaxo Group Ltd |
Novel compounds
|
US6951882B2
(en)
|
2002-12-12 |
2005-10-04 |
Janssen Pharmaceutica N.V. |
Substituted 4-phenyl-[1,3]-dioxanes
|
KR20050114242A
(ko)
|
2003-03-26 |
2005-12-05 |
액테리온 파마슈티칼 리미티드 |
오렉신 수용체 길항제로서 이용되는테트라하이드로이소퀴놀릴 아세트아마이드 유도체
|
JP2007523846A
(ja)
|
2003-04-28 |
2007-08-23 |
アクテリオン ファマシューティカルズ リミテッド |
キノキサリノン誘導体
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
ATE444732T1
(de)
|
2003-08-07 |
2009-10-15 |
Allergan Inc |
Zusammensetzungen zur abgabe von therapeutika in die augen und verfahren zu ihrer herstellung und verwendung
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
HUP0304101A3
(en)
|
2003-12-22 |
2008-10-28 |
Sanofi Aventis |
Pyrazole derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
WO2005118548A1
(en)
|
2004-03-01 |
2005-12-15 |
Actelion Pharmaceuticals Ltd |
Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
|
WO2006067224A2
(en)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Spiro-benzodioxole and spiro-benzodioxane compounds as orexin receptor antagonists
|
EP1871752A4
(en)
|
2005-04-12 |
2009-09-30 |
Merck & Co Inc |
ANTAGONISTS OF THE AMIDOPROPOXYPHENYLOREXIN RECEPTOR
|
CN101189347A
(zh)
|
2005-05-03 |
2008-05-28 |
通信探索公司 |
反转探针及其用于核酸检测的用途
|
US20090118200A1
(en)
|
2005-05-23 |
2009-05-07 |
Bergman Jeffrey M |
Proline bis-amide orexin receptor antagonists
|
CA2617324A1
(en)
|
2005-08-04 |
2007-02-15 |
Merck & Co., Inc. |
Aminoethane sulfonamide orexin receptor antagonists
|
CA2620124A1
(en)
|
2005-08-26 |
2007-03-01 |
Merck And Co., Inc. |
Diazaspirodecane orexin receptor antagonists
|
EP1954276A2
(en)
|
2005-11-22 |
2008-08-13 |
Merck & Co., Inc. |
Indole orexin receptor antagonists
|
CN101009515A
(zh)
|
2006-01-24 |
2007-08-01 |
华为技术有限公司 |
通信终端设备管理方法及通信终端
|
TW200800020A
(en)
|
2006-01-26 |
2008-01-01 |
Basf Ag |
Methods to use 3-pyridyl derivatives as pesticides
|
FR2896798A1
(fr)
|
2006-01-27 |
2007-08-03 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
FR2896799B1
(fr)
|
2006-02-02 |
2008-03-28 |
Sanofi Aventis Sa |
Derives de sulfonamides, leur preparation et leur application en therapeutique
|
US20090105318A1
(en)
|
2006-03-29 |
2009-04-23 |
Coleman Paul J |
Amidoethylthioether Orexin Receptor Antagonists
|
WO2007116374A1
(en)
|
2006-04-11 |
2007-10-18 |
Actelion Pharmaceuticals Ltd |
Novel sulfonamide compounds
|
DE602007012072D1
(de)
|
2006-04-26 |
2011-03-03 |
Actelion Pharmaceuticals Ltd |
Orantagonisten
|
WO2007143813A1
(en)
|
2006-06-16 |
2007-12-21 |
Husky Injection Molding Systems Ltd. |
Preventative maintenance update system
|
JP2009543790A
(ja)
|
2006-07-14 |
2009-12-10 |
メルク エンド カムパニー インコーポレーテッド |
2−置換プロリンビス−アミドオレキシン受容体アンタゴニスト
|
US20090192143A1
(en)
|
2006-07-14 |
2009-07-30 |
Cox Christopher D |
Substituted diazepan orexin receptor antagonists
|
EP2049110B1
(en)
|
2006-07-14 |
2014-08-20 |
Merck Sharp & Dohme Corp. |
Bridged diazepan orexin receptor antagonists
|
CN101506199A
(zh)
|
2006-08-15 |
2009-08-12 |
埃科特莱茵药品有限公司 |
用作食欲素受体拮抗剂的氮杂环丁烷化合物
|
EP2059520B1
(en)
|
2006-08-28 |
2010-02-24 |
Actelion Pharmaceuticals Ltd. |
1,4,5,6,7,8-hexahydro-i,2,5-triaza-azulene derivatives as orexin receptor antagonists
|
KR20090077051A
(ko)
|
2006-09-29 |
2009-07-14 |
액테리온 파마슈티칼 리미티드 |
3-아자-비시클로[3.1.0]헥산 유도체
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
JP2010511038A
(ja)
|
2006-12-01 |
2010-04-08 |
アクテリオン ファーマシューティカルズ リミテッド |
オレキシン受容体阻害剤としての3−ヘテロアリール(アミノ又はアミド)−1−(ビフェニル又はフェニルチアゾリル)カルボニルピペリジン誘導体
|
ATE545647T1
(de)
|
2006-12-22 |
2012-03-15 |
Actelion Pharmaceuticals Ltd |
5,6,7,8-tetrahydro-imidazoä1,5-aüpyrazinderivat
|
AR064561A1
(es)
|
2006-12-28 |
2009-04-08 |
Actelion Pharmaceuticals Ltd |
Derivados de 2-aza-biciclo[3.1.0]hexano y su uso en la preparacion de un medicamento para el tratamiento de enfermedades relacionadas con disfunciones generales del sistema de la orexina.
|
WO2008087611A2
(en)
|
2007-01-19 |
2008-07-24 |
Actelion Pharmaceuticals Ltd |
Pyrrolidine- and piperidine- bis-amide derivatives
|
US8410142B2
(en)
|
2007-03-02 |
2013-04-02 |
Merck Sharp & Dohme Corp. |
Bipyridine carboxamide orexin receptor antagonists
|
CA2679039A1
(en)
|
2007-03-05 |
2008-09-12 |
F. Hoffmann-La Roche Ag |
Aminoamides as orexin antagonists
|
DE602008006368D1
(de)
|
2007-03-15 |
2011-06-01 |
Hoffmann La Roche |
Malonamide als orexin-antagonisten
|
CL2008000836A1
(es)
|
2007-03-26 |
2008-11-07 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de tiazolidina, antagonistas del receptor de orexina; composicion farmaceutica que los comprende; y su uso en el tratamiento de neurosis emocional, depresion grave, trastornos psicoticos, alzheimer, parkinson, dolor, entre otras.
|
MX2009010727A
(es)
|
2007-04-04 |
2009-10-26 |
Hoffmann La Roche |
Heterociclos como antagonistas de orexina.
|
CA2685743A1
(en)
|
2007-05-14 |
2008-11-20 |
Actelion Pharmaceuticals Ltd |
2-cyclopropyl-thiazole derivatives
|
CA2688776A1
(en)
|
2007-05-18 |
2008-11-27 |
Merck & Co., Inc. |
Oxo bridged diazepan orexin receptor antagonists
|
EP2150115B1
(en)
|
2007-05-23 |
2013-09-18 |
Merck Sharp & Dohme Corp. |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
MY148544A
(en)
|
2007-05-23 |
2013-04-30 |
Merck Sharp & Dohme |
Pyridyl piperidine orexin receptor antagonists
|
BRPI0813218A2
(pt)
|
2007-07-03 |
2014-12-23 |
Actelion Pharmaceuticals Ltd |
Composto, composição farmacêutica que o contém como princípio ativo e uso do composto.
|
KR20100046047A
(ko)
|
2007-07-27 |
2010-05-04 |
액테리온 파마슈티칼 리미티드 |
2-아자-비시클로[3.3.0]옥탄 유도체
|
DE602008004265D1
(de)
|
2007-07-27 |
2011-02-10 |
Actelion Pharmaceuticals Ltd |
Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate
|
US20090036422A1
(en)
|
2007-08-02 |
2009-02-05 |
Henner Knust |
Monoamide derivatives as orexin receptor antagonists
|
AU2008284268A1
(en)
|
2007-08-09 |
2009-02-12 |
Merck & Co., Inc. |
Pyridine carboxamide orexin receptor antagonists
|
AU2008287445A1
(en)
|
2007-08-10 |
2009-02-19 |
Cortex Pharmaceuticals, Inc. |
Bicyclic amides for enhancing glutamatergic synaptic responses
|
ES2400830T3
(es)
|
2007-08-15 |
2013-04-12 |
Actelion Pharmaceuticals Ltd. |
Derivados de 1,2-diamido-etileno como antagonistas de orexina
|
CN101874030B
(zh)
|
2007-09-24 |
2012-11-14 |
埃科特莱茵药品有限公司 |
用作食欲素受体拮抗剂的吡咯烷和哌啶
|
US8362009B2
(en)
|
2007-10-29 |
2013-01-29 |
Merck Sharp & Dohme Corp. |
Substituted diazepan orexin receptor antagonists
|
US8084464B2
(en)
|
2007-12-18 |
2011-12-27 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
CN101903372B
(zh)
|
2007-12-21 |
2014-06-18 |
弗·哈夫曼-拉罗切有限公司 |
作为食欲肽受体拮抗剂的杂芳基衍生物
|
EP2245006B1
(en)
|
2008-01-21 |
2011-06-01 |
F. Hoffmann-La Roche AG |
Sulfonamides as orexin antagonists
|
ES2367341T3
(es)
|
2008-02-12 |
2011-11-02 |
F. Hoffmann-La Roche Ag |
Derivados de piperidina-sulfonamida.
|
BRPI0908096A2
(pt)
|
2008-02-21 |
2015-08-25 |
Actelion Pharmaceuticals Ltd |
Derivado de 2-aza-biciclo [2.2.1] heptano
|
GB0806536D0
(en)
|
2008-04-10 |
2008-05-14 |
Glaxo Group Ltd |
Novel compounds
|
CN102056920A
(zh)
|
2008-06-11 |
2011-05-11 |
埃科特莱茵药品有限公司 |
用作食欲素受体拮抗剂的四唑化合物
|
KR20110025915A
(ko)
|
2008-06-16 |
2011-03-14 |
에프. 호프만-라 로슈 아게 |
오렉시닌 수용체 길항제로서 헤테로방향족 모노아마이드
|
EP2307417A2
(en)
|
2008-06-25 |
2011-04-13 |
Actelion Pharmaceuticals Ltd. |
5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
|
CN102083827A
(zh)
|
2008-07-07 |
2011-06-01 |
埃科特莱茵药品有限公司 |
作为食欲素受体拮抗剂的噻唑烷化合物
|
CN102083820B
(zh)
|
2008-07-29 |
2013-07-17 |
弗·哈夫曼-拉罗切有限公司 |
作为食欲肽拮抗剂的吡咯烷-3-基甲基-胺
|
AR072899A1
(es)
|
2008-08-07 |
2010-09-29 |
Merck Sharp & Dohme |
Derivados de terpiridina-carboxamida antagonistas de receptores de orexina, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del insomnio y la obesidad.
|
EP2161266A1
(en)
|
2008-08-22 |
2010-03-10 |
EVOTEC Neurosciences GmbH |
Benzofuran derivatives as orexin receptor antagonists
|
WO2010038200A1
(en)
|
2008-10-01 |
2010-04-08 |
Actelion Pharmaceuticals Ltd |
Oxazolidine compounds as orexin receptor antagonists
|
MX2011003191A
(es)
|
2008-10-14 |
2011-04-27 |
Actelion Pharmaceuticals Ltd |
Derivados de fenetilamida y sus analogos heterociclicos.
|
JP2012506374A
(ja)
|
2008-10-21 |
2012-03-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
2,5−二置換ピペリジンオレキシン受容体アンタゴニスト
|
CA2739917A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted morpholine orexin receptor antagonists
|
AU2009307921A1
(en)
|
2008-10-21 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Disubstituted azepan orexin receptor antagonists
|
EP2350061B1
(en)
|
2008-10-21 |
2013-08-14 |
Merck Sharp & Dohme Corp. |
2,3-disubstituted piperidine orexin receptor antagonists
|
JP2012506377A
(ja)
|
2008-10-21 |
2012-03-15 |
メルク・シャープ・エンド・ドーム・コーポレイション |
2,4−二置換フェニルカルボキサミド・オレキシン受容体アンタゴニスト
|
US8710076B2
(en)
|
2008-10-21 |
2014-04-29 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted piperidine orexin receptor antagonists
|
EP2349262B1
(en)
|
2008-10-30 |
2014-06-25 |
Merck Sharp & Dohme Corp. |
2,5-disubstituted phenyl carboxamide orexin receptor antagonists
|
JP5635991B2
(ja)
|
2008-10-30 |
2014-12-03 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
イソニコチンアミドオレキシン受容体アンタゴニスト
|
AU2009308982A1
(en)
|
2008-10-30 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Pyridazine carboxamide orexin receptor antagonists
|
WO2010060471A1
(en)
|
2008-11-26 |
2010-06-03 |
Glaxo Group Limited |
Piperidine derivatives useful as orexin receptor antagonists
|
EP2358713A1
(en)
|
2008-11-26 |
2011-08-24 |
Glaxo Group Limited |
Imidazopyridazine derivatives acting as orexin antagonists
|
JP2012509910A
(ja)
|
2008-11-26 |
2012-04-26 |
グラクソ グループ リミテッド |
新規の化合物
|
AR074426A1
(es)
|
2008-12-02 |
2011-01-19 |
Glaxo Group Ltd |
Compuesto de n-(((1s,4s,6s)-3-(2-piridinilcarbonil)3-azabiciclo (4,1.0)hept-4-il) metil)-2-heteroarilamina, su uso para la prepracion de un medicamento para el tratamiento de una enfermedad que requiere un antagonista de un receptor de orexina humana y composicion farmaceutica que lo comprende
|
CA2745433A1
(en)
|
2008-12-02 |
2010-06-10 |
Glaxo Group Ltd. |
N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl] methyl}-2-heteroarylamine derivatives and uses thereof
|
JP2010155827A
(ja)
|
2008-12-04 |
2010-07-15 |
Takeda Chem Ind Ltd |
スピロ環化合物
|
GB0823467D0
(en)
|
2008-12-23 |
2009-01-28 |
Glaxo Group Ltd |
Novel Compounds
|
US20100222396A1
(en)
|
2009-01-30 |
2010-09-02 |
Novartis Ag |
4-aryl-butane-1,3-diamides
|
SG175026A1
(en)
|
2009-04-24 |
2011-11-28 |
Glaxo Group Ltd |
3 -azabicyclo [4.1.0] heptanes used as orexin antagonists
|
EP2451281A4
(en)
|
2009-07-09 |
2013-03-13 |
Merck Sharp & Dohme |
ANTAGONISTS OF OREXIN RECEPTORS BASED ON TETRAHYDRONAPHTHYRIDINE
|
EP2275421A1
(en)
|
2009-07-15 |
2011-01-19 |
Rottapharm S.p.A. |
Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
|
WO2011016234A1
(en)
|
2009-08-04 |
2011-02-10 |
Raqualia Pharma Inc. |
Picolinamide derivatives as ttx-s blockers
|
JP2013502448A
(ja)
|
2009-08-24 |
2013-01-24 |
グラクソ グループ リミテッド |
オレキシンアンタゴニストとして用いられるピペリジン誘導体
|
WO2011023578A1
(en)
|
2009-08-24 |
2011-03-03 |
Glaxo Group Limited |
5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder
|
USRE48841E1
(en)
|
2009-10-23 |
2021-12-07 |
Janssen Pharmaceutica Nv |
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
|
WO2011050202A1
(en)
|
2009-10-23 |
2011-04-28 |
Janssen Pharmaceutica Nv |
Fused heterocyclic compounds as orexin receptor modulators
|
EP2491034B1
(en)
|
2009-10-23 |
2013-12-18 |
Janssen Pharmaceutica, N.V. |
Fused heterocyclic compounds as orexin receptor modulators
|
WO2011053522A1
(en)
|
2009-10-29 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Tertiary amide orexin receptor antagonists
|
US20120258957A1
(en)
|
2009-11-23 |
2012-10-11 |
Matilda Jane Bingham |
Heterocyclic derivatives
|
WO2011073316A1
(en)
|
2009-12-18 |
2011-06-23 |
Novartis Ag |
4-aryl-butane-1,3-diamides
|
CN102762567A
(zh)
|
2009-12-21 |
2012-10-31 |
诺瓦提斯公司 |
作为食欲肽受体拮抗剂的二氮杂-螺[5.5]十一烷类
|
ES2460915T3
(es)
|
2009-12-21 |
2014-05-16 |
Novartis Ag |
Piridinas fusionadas con heteroarilo disustituido
|
WO2011138265A2
(en)
|
2010-05-03 |
2011-11-10 |
Evotec Ag |
Indole and indazole derivatives as orexin receptor antagonists
|
WO2011138266A1
(en)
|
2010-05-03 |
2011-11-10 |
Evotec Ag |
Indolizine and imidazopyridine derivatives as orexin receptor antagonists
|
SG191103A1
(en)
|
2010-12-17 |
2013-08-30 |
Taisho Pharmaceutical Co Ltd |
Pyrazole derivative
|
US20120165339A1
(en)
|
2010-12-22 |
2012-06-28 |
Eisai R&D Management Co., Ltd. |
Cyclopropane derivatives
|
US20120165331A1
(en)
|
2010-12-22 |
2012-06-28 |
Sangamesh Badiger |
Di/tri-aza-spiro-C9-C11alkanes
|
WO2012085857A1
(en)
|
2010-12-22 |
2012-06-28 |
Actelion Pharmaceuticals Ltd |
3,8-diaza-bicyclo[4.2.0]oct-3-yl amides
|
WO2012089606A1
(en)
|
2010-12-28 |
2012-07-05 |
Glaxo Group Limited |
Azabicyclo [4.1.0] hept - 4 - yl derivatives as human orexin receptor antagonists
|
WO2012089607A1
(en)
|
2010-12-28 |
2012-07-05 |
Glaxo Group Limited |
Novel compounds with a 3a-azabicyclo [4.1.0] heptane core acting on orexin receptors
|
ES2541531T3
(es)
|
2011-02-18 |
2015-07-21 |
Actelion Pharmaceuticals Ltd. |
Nuevos derivados de pirazol e imidazol útiles como antagonistas de orexina
|
WO2012114252A1
(en)
|
2011-02-21 |
2012-08-30 |
Actelion Pharmaceuticals Ltd |
Novel indole and pyrrolopyridine amides
|
US9586962B2
(en)
|
2011-04-20 |
2017-03-07 |
Janssen Pharmaceutica Nv |
Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
|
JPWO2012153729A1
(ja)
|
2011-05-10 |
2014-07-31 |
大正製薬株式会社 |
ヘテロ芳香環誘導体
|
EP2730573A4
(en)
|
2011-07-05 |
2014-12-03 |
Taisho Pharmaceutical Co Ltd |
METHYLPIPERIDINDERIVAT
|
WO2013050938A1
(en)
|
2011-10-04 |
2013-04-11 |
Actelion Pharmaceuticals Ltd |
3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
EP2768305A4
(en)
|
2011-10-21 |
2015-04-29 |
Merck Sharp & Dohme |
2,5-DISUBSTITUTED THIOMORPHOLIN OREXINE RECEPTOR ANTAGONISTS
|
EP2771001A4
(en)
|
2011-10-25 |
2015-03-25 |
Merck Sharp & Dohme |
PIPERIDINYL-alkyne-orexin
|
WO2013062858A1
(en)
|
2011-10-25 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Isoxazolopyridine orexin receptor antagonists
|
MX343837B
(es)
|
2011-11-08 |
2016-11-24 |
Actelion Pharmaceuticals Ltd |
Derivados de 2 - (1,2,3 -triazol - 2 - il) benzamida y 3 - (1,2,3 - triazol - 2 - il) picolinamida.
|
ITMI20112329A1
(it)
|
2011-12-21 |
2013-06-22 |
Rottapharm Spa |
Nuovi derivati spiro amminici
|
US9440982B2
(en)
|
2012-02-07 |
2016-09-13 |
Eolas Therapeutics, Inc. |
Substituted prolines/piperidines as orexin receptor antagonists
|
MX2014009281A
(es)
|
2012-02-07 |
2015-01-12 |
Eolas Therapeutics Inc |
Prolinas/piperidinas sustituidas como antagonistas del receptor de orexina.
|
CN104114524B
(zh)
|
2012-02-17 |
2016-08-17 |
卫材R&D管理有限公司 |
用于食欲肽-2受体拮抗剂的合成的方法和化合物
|
ITMI20120322A1
(it)
*
|
2012-03-01 |
2013-09-02 |
Rottapharm Spa |
Composti di 4,4-difluoro piperidina
|
ITMI20120424A1
(it)
|
2012-03-19 |
2013-09-20 |
Rottapharm Spa |
Composti chimici
|
TW201613891A
(en)
|
2014-02-12 |
2016-04-16 |
Eolas Therapeutics Inc |
Substituted prolines / piperidines as orexin receptor antagonists
|